Piramal Enterprises planning to shift borrowing mix to longer-term funding sources

12 Jul 2019

Piramal Enterprises is planning to shift its borrowing mix to longer-term funding sources, and significantly reduce dependence on commercial papers. The company will also continue to build resilience by further strengthening its liability and asset side.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Related Piramal Enterprises Ltd. Links:

Piramal Enterprises Share Price

1253.15 -30.75 (-2.40%) Sep 29, 18:01
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 505.60
Dr. Reddys Lab 5083.50
Lupin 998.00
Piramal Enterprises 1253.15
Cadila Healthcare 387.55
View more..
Sensex vs Piramal Enterprises
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719